Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NOS enhancer BZ371A

A synthetic peptide and nitric oxide synthase (NOS) enhancer, with potential vasodilating and anti-inflammatory activities. Upon topical application, NOS enhancer BZ371A induces local expression of NOS, thereby increasing endogenous NO production and NO level. This may result in vasodilation and penile erection when BZ371A is topically applied to the genital area. BZ371A may also be topically applied to other areas such as the eye and the skin for the treatment of glaucoma and various skin conditions through its vasodilating and anti-inflammatory actions. Nitric oxide is an important intercellular signaling molecule that acts as a vasodilator and an immune and inflammatory mediator.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:nitric oxide synthase enhancer BZ371A
NO synthase enhancer BZ371A
Code name:BZ 371A
BZ-371A
BZ371A
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search